Interactive Transcript
0:01
Patients who are at high risk for lung cancer are also at
0:03
high risk for cardiovascular disease.
0:06
In the National Lung Cancer Screening trial,
0:08
we saw a 20% reduction in lung cancer specific mortality,
0:12
but we saw a nearly 7% reduction, all cause mortality.
0:16
Much of that is attributed to cardiovascular disease.
0:20
We'll talk about the most common cardiovascular
0:24
incidental findings that you can see on a CT examination.
0:27
Some people would say the term incidental is maybe not the
0:30
most correct term to use
0:31
because we expect patients with a heavy history
0:34
of cigarette smoking to have atheros disease,
0:37
to have lung disease in the form of emphysema.
0:40
The question in front
0:42
of us is when we identify them is are they
0:44
significant for the patient?
0:46
Do they need to be managed
0:47
and can they impact their future morbidity and mortality?
0:51
So we'll talk about the frequency
0:52
of these most common cardiovascular sent findings,
0:55
and the three that we're gonna talk about
0:57
specifically our corona arterial calcification.
0:59
Something that most people are quite familiar
1:01
with from the days of beginning.
1:03
The Atkinson scoring for dedicated coronary calcium cts
1:08
to a dilated aorta aortic aneurysms
1:11
for which there are guidelines on which to make decisions,
1:14
and then something that doesn't get as much recognition,
1:16
which is beginning to be known as important
1:19
for patient's health, which is increased epicardial fat.
1:23
If we look at the first 1.7 million screens in the
1:28
ACRs lung cancer screening registry, we can look at how
1:31
commonly cardiovascular findings occur.
1:34
Remember, an S finding or the S modifier is a significant
1:38
or potentially significant finding found on a lung
1:41
cancer screening ct.
1:43
The first time you identify in the abnormality,
1:45
it's now a new significant
1:46
or potentially significant finding.
1:48
But if the finding is unchanged on subsequent cts,
1:52
it's no longer an S modifier.
1:55
However, it still may be important for you
1:57
to put it in the impression of your report.
1:59
Coronary arterial calcification occurred on the first
2:04
1.7 million screens about 11.6% of the time
2:08
and represented 62% of all the patients
2:12
who have an S finding.
2:14
We report the S modifier
2:16
for coronary art trial calcification generally in patients
2:19
who have moderate
2:20
or severe coronary art trail calcification.
2:23
Another important cardiovascular finding
2:26
that's incidental on lung screening.
2:28
cts are aortic aneurysms
2:30
and generally thoracic aortic aneurysms are silent
2:34
until a patient either has it found incidentally,
2:36
usually getting a chest CT for some other reason, or
2:40
because they come in with an acute aortic emergency due
2:44
to the RUP of aortic aneurysm.
2:46
Abdominal aortic aneurysms in contrast, have other signs
2:50
of disease such as potentially a palpable mass
2:53
or other ways of screening, such
2:55
as ultrasound screening is recommended
2:57
in high risk patients.
3:00
So these are two really important categories
3:02
that we should look at on our lung cancer screening.
3:04
cts coronary trial calcification
3:07
for which lipid modification is gonna be important in
3:09
cardiovascular risk assessment, an aortic aneurysms
3:12
for which their guidelines on which to base the frequency
3:15
of followup imaging and the inclusion of echocardiography.
3:20
If we look at the American College
3:21
of Radiology's lung cancer screening, incidental findings,
3:25
quick reference guide,
3:26
we have a specific section on these cardiovascular findings
3:30
for the thoracic aorta.
3:32
If it's a little bit dilated,
3:33
but still considered within normal, for example,
3:36
an ascending aorta under 40
3:38
to 42 millimeters is considered normal.
3:41
You might call that fusiform dilatation
3:43
or mild ectasia
3:44
of the thoracic aorta in the ascending component
3:47
and no follow-up recommendation may be made when the ascend
3:51
aorta hits 42 millimeters in diameter.
3:53
This is where recommended surveillance occurs
3:56
and potentially a cardiology
3:57
or cardiac surgery consultation.
4:00
Commonly, an echocardiogram is recommended
4:02
to evaluate the aortic valve for evidence of stenosis
4:05
or insufficiency, which can be the cause
4:08
or be related to an ascent aorta that is dilated
4:12
as ascent aortic increase in size.
4:14
The risk of rupture increases reaching surgical thresholds
4:18
of approximately 5.5 centimeters in the a c aorta
4:22
for most patients, but five centimeters for patients
4:26
who have underlying connective tissue diseases
4:29
that can cause rapid increase in size
4:32
and increase the risk of acute aortic emergencies, such
4:35
as patients with Aler Danlos syndrome or LODE syndrome.
4:39
We can certainly look at the heart
4:41
and pericardium for abnormal chamber size
4:43
for pericardial thickening calcification
4:45
or pericardial effusion and manage
4:47
accordingly as you would in a standard chest
4:50
CT interpretation.
4:51
Coronary arterial calcification,
4:53
we're gonna talk about a little bit more detail,
4:55
and in the main pulmonary arteries,
4:57
we can measure them for dilatation.
4:59
Generally, under 31 millimeters is considered a normal
5:03
diameter main pulmonary artery and 31 millimeters
5:06
or larger as considered enlarged.
5:08
However, people have called into question the
5:11
31 millimeter criterion.
5:13
The ACRs white paper
5:15
for incidental fines in the chest uses this size threshold.
5:19
However, many cardiologists considered the appropriate size
5:22
threshold closer to 33
5:23
or 34 millimeters, believing there were over calling
5:27
possible pulmonary hypertension by using such
5:29
as a low threshold
5:31
and subjecting these patients to unnecessary referral
5:34
and unnecessary testing.
5:36
So in our practice, we're using a threshold
5:38
of about 33 millimeters
5:40
to call mild pulmonary tear enlargement.